Literature DB >> 3191592

Exercise-induced hypotension in a male population. Criteria, causes, and prognosis.

P Dubach1, V F Froelicher, J Klein, D Oakes, M Grover-McKay, R Friis.   

Abstract

The objective of this study was to demonstrate the causes, optimal definition, and predictive value of exercise-induced hypotension occurring during treadmill testing. This study included all patients referred for clinical reasons to the Long Beach Veterans Administration Medical Center treadmill laboratory and then followed for a 2-year period for cardiac events. The population consisted of 2,036 patients who underwent testing from April 4, 1984, to May 7, 1987, 131 of whom exhibited exercise-induced hypotension (6.4%). We found that exercise-induced hypotension is usually related to myocardial ischemia or myocardial infarction, is best defined as a drop in systolic blood pressure during exercise below the standing preexercise value, and indicates a significantly increased risk for cardiac events (3.2-fold, p less than 0.005). This increased risk was not found in those having no previous myocardial infarction or no signs or symptoms of ischemia during the exercise test, and the increased risk was also not found in those undergoing a treadmill test within 3 weeks after a myocardial infarction. Exercise-induced hypotension appeared to be reversed by revascularization procedures, but confirmation of a beneficial effect on survival requires a randomized trial. The clinical importance of this study is that we have demonstrated that a drop in systolic blood pressure below standing preexercise values during treadmill testing indicates an increased risk for cardiac events except in certain subsets of patients.

Entities:  

Mesh:

Year:  1988        PMID: 3191592     DOI: 10.1161/01.cir.78.6.1380

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  13 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

3.  Medical hazards of a four-km fun run.

Authors:  H Bethell; D Jewell; P Burke
Journal:  Br J Sports Med       Date:  1991-12       Impact factor: 13.800

4.  Forearm vascular responses during semierect dynamic leg exercise in patients following myocardial infarction.

Authors:  H Thomson; J Morris-Thurgood; J Atherton; M P Frenneaux
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

5.  Exercise Blood Pressure Guidelines: Time to Re-evaluate What is Normal and Exaggerated?

Authors:  Katharine D Currie; John S Floras; Andre La Gerche; Jack M Goodman
Journal:  Sports Med       Date:  2018-08       Impact factor: 11.136

6.  ST elevation in recovery post exercise with normal coronary arteries.

Authors:  Reza Aghamohammadzadeh; Suhaib Magdi El-Omar; Derek Rowlands; Magdi El-Omar
Journal:  BMJ Case Rep       Date:  2019-07-08

Review 7.  Blood Pressure Response to Exercise and Cardiovascular Disease.

Authors:  Martin G Schultz; Andre La Gerche; James E Sharman
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

8.  Abnormal blood-pressure response to exercise and oxygen consumption in patients with hypertrophic cardiomyopathy.

Authors:  Quirino Ciampi; Sandro Betocchi; Maria Angela Losi; Adele Ferro; Alberto Cuocolo; Raffaella Lombardi; Bruno Villari; Massimo Chiariello
Journal:  J Nucl Cardiol       Date:  2007-10-22       Impact factor: 5.952

9.  Exercise induced vasodepressor syncope.

Authors:  J F Sneddon; G Scalia; D E Ward; W J McKenna; A J Camm; M P Frenneaux
Journal:  Br Heart J       Date:  1994-06

10.  Blunted heart rate recovery is associated with exaggerated blood pressure response during exercise testing.

Authors:  Umuttan Dogan; Mehmet Akif Duzenli; Kurtulus Ozdemir; Hasan Gok
Journal:  Heart Vessels       Date:  2012-10-19       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.